The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment: Suggested disease management guidelines

M. Brian Fennerty; Donald Castell; A. Mark Fendrick; Michael Halpern; Daniel Johnson; Peter J. Kahrilas; David Lieberman; Joel E. Richter; Richard E. Sampliner

doi:10.1001/archinte.156.5.477

The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment: Suggested disease management guidelines

M. Brian Fennerty^*, Donald Castell, A. Mark Fendrick, Michael Halpern, Daniel Johnson, Peter J. Kahrilas, David Lieberman, Joel E. Richter, Richard E. Sampliner

^*Corresponding author for this work

Medicine

Research output: Contribution to journal › Review article › peer-review

126 Scopus citations

Abstract

A group of experts from gastroenterology, internal medicine, health economics, medical outcomes, and managed care met in San Francisco, Calif, on September 27, 1994, in an effort to develop clinically and economically effective disease management guidelines to assist physicians in their treatment of gastroesophageal reflux disease in a managed care environment. This article represents a consensus opinion based on the evidence and expert interpretation at the time of that meeting.

Original language	English (US)
Pages (from-to)	477-484
Number of pages	8
Journal	Archives of Internal Medicine
Volume	156
Issue number	5
DOIs	https://doi.org/10.1001/archinte.156.5.477
State	Published - Mar 11 1996

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.1001/archinte.156.5.477

Cite this

Fennerty, M. B., Castell, D., Fendrick, A. M., Halpern, M., Johnson, D., Kahrilas, P. J., Lieberman, D., Richter, J. E., & Sampliner, R. E. (1996). The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment: Suggested disease management guidelines. Archives of Internal Medicine, 156(5), 477-484. https://doi.org/10.1001/archinte.156.5.477

@article{e509e0889d70427f8638e9a184f315ba,

title = "The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment: Suggested disease management guidelines",

abstract = "A group of experts from gastroenterology, internal medicine, health economics, medical outcomes, and managed care met in San Francisco, Calif, on September 27, 1994, in an effort to develop clinically and economically effective disease management guidelines to assist physicians in their treatment of gastroesophageal reflux disease in a managed care environment. This article represents a consensus opinion based on the evidence and expert interpretation at the time of that meeting.",

author = "Fennerty, {M. Brian} and Donald Castell and Fendrick, {A. Mark} and Michael Halpern and Daniel Johnson and Kahrilas, {Peter J.} and David Lieberman and Richter, {Joel E.} and Sampliner, {Richard E.}",

year = "1996",

month = mar,

day = "11",

doi = "10.1001/archinte.156.5.477",

language = "English (US)",

volume = "156",

pages = "477--484",

journal = "Archives of Internal Medicine",

issn = "0003-9926",

publisher = "American Medical Association",

number = "5",

}

TY - JOUR

T1 - The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment

T2 - Suggested disease management guidelines

AU - Fennerty, M. Brian

AU - Castell, Donald

AU - Fendrick, A. Mark

AU - Halpern, Michael

AU - Johnson, Daniel

AU - Kahrilas, Peter J.

AU - Lieberman, David

AU - Richter, Joel E.

AU - Sampliner, Richard E.

PY - 1996/3/11

Y1 - 1996/3/11

N2 - A group of experts from gastroenterology, internal medicine, health economics, medical outcomes, and managed care met in San Francisco, Calif, on September 27, 1994, in an effort to develop clinically and economically effective disease management guidelines to assist physicians in their treatment of gastroesophageal reflux disease in a managed care environment. This article represents a consensus opinion based on the evidence and expert interpretation at the time of that meeting.

AB - A group of experts from gastroenterology, internal medicine, health economics, medical outcomes, and managed care met in San Francisco, Calif, on September 27, 1994, in an effort to develop clinically and economically effective disease management guidelines to assist physicians in their treatment of gastroesophageal reflux disease in a managed care environment. This article represents a consensus opinion based on the evidence and expert interpretation at the time of that meeting.

UR - http://www.scopus.com/inward/record.url?scp=0029869458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029869458&partnerID=8YFLogxK

U2 - 10.1001/archinte.156.5.477

DO - 10.1001/archinte.156.5.477

M3 - Review article

C2 - 8604953

AN - SCOPUS:0029869458

SN - 0003-9926

VL - 156

SP - 477

EP - 484

JO - Archives of Internal Medicine

JF - Archives of Internal Medicine

IS - 5

ER -

The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment: Suggested disease management guidelines

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this